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Abstract
Immunization with irradiated sporozoites is currently the most effective vaccination strategy against liver stages of malaria
parasites, yet the mechanisms underpinning the success of this approach are unknown. Here we show that the complete
development of protective CD8+ T cell responses requires prolonged antigen presentation. Using TCR transgenic cells
specific for the malaria circumsporozoite protein, a leading vaccine candidate, we found that sporozoite antigen persists for
over 8 weeks after immunization—a remarkable finding since irradiated sporozoites are incapable of replication and do not
differentiate beyond early liver stages. Persisting antigen was detected in lymphoid organs and depends on the presence of
CD11c+ cells. Prolonged antigen presentation enhanced the magnitude of the CD8+ T cell response in a number of ways.
Firstly, reducing the time primed CD8+ T cells were exposed to antigen in vivo severely reduced the final size of the
developing memory population. Secondly, fully developed memory cells expanded in previously immunized mice but not
when transferred to naı¨ve animals. Finally, persisting antigen was able to prime naı¨ve cells, including recent thymic
emigrants, to become functional effector cells capable of eliminating parasites in the liver. Together these data show that
the optimal development of protective CD8+ T cell immunity against malaria liver stages is dependent upon the prolonged
presentation of sporozoite-derived antigen.
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Introduction
Immunization with irradiated malaria sporozoites can induce
sterile protection against subsequent challenge with live parasites
in both mice and men [1,2]. In murine models protection is
mediated at least in part by CD8+ T cells [3,4]. Understanding the
mechanistic underpinnings of this protective response is consid-
ered essential if we are to emulate it with a practical and effective
vaccine. It has been proposed previously, based on the detection of
parasite remnants in the livers of immunized mice, that antigen
persists after sporozoite immunization and that this may help
generate protective immune responses [5]; however, there is no
evidence that this material, assumed to be of parasite origin, is
immunogenic or that it is presented to effector cells of the immune
system.
The requirement for antigen in the full development of effector
and memory responses in different microbial systems is an area of
controversy. Studies, that are now considered seminal, have
proposed that only a short (,24 hour) exposure to antigen is
required to trigger the complete developmental program of CD8+
T cells [6,7,8]. Following initial antigen exposure CD8+ T cells
expand into effector cells before forming a numerically stable
memory population, a process that has been characterized as T
cells on ‘‘autopilot’’ [9]. In the longer term, persisting antigen
during chronic viral infection is often considered detrimental to T
cell immunity as over-stimulated T cells may become exhausted
and lose effector function [10,11]. However, not all data suggests
short exposures to antigen are optimal for T cell responses. The
largest antigen specific CD8+ T cell responses observed in humans
are seen during chronic infection with various Herpesviruses
[12,13]. For Herpesviruses and other chronic infections it maybe
that continued recruitment of thymic emigrants by the continued
presence of foreign antigen can maximize and maintain the
immune response [14,15]. Recently a number of authors have
reported antigen persistence after acute viral infections [16,17,18].
Although the significance of this prolonged antigen presentation is
not fully understood, some authors have suggested that it may
have an important role in maintaining protective CD8+ T cell
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responses [18], while others suggest that this process contributes
little to CD8+ T cell mediated immunity [19].
Most studies examining the effect of antigen exposure on CD8+
T cell responses have studied persistence following infection with
live pathogens, often with little distinction being made between the
duration of infection and the duration of antigen presentation.
Irradiated Plasmodium sporozoites are incapable of division and
differentiation and induce little or no inflammation [20] yet they
stimulate robust protective CD8+ T cell responses; therefore, this
is an excellent system to study whether antigen alone can persist in
the absence of persisting infection. By transferring TCR transgenic
T cells specific for the circumsporozoite (CS) protein, a leading
vaccine candidate antigen, we were able to show that CS antigen
persists for more than 8 weeks after immunization. Our studies
show that prolonged antigen presentation drives the maximal
expansion of effector cells, can stimulate the proliferation of
established memory cells and recruit naı¨ve cells, including recent
thymic emigrants to the immune response. Thus prolonged
antigen presentation may be required for the full development of
CD8+ T cell mediated protective immunity.
Results
Prolonged antigen presentation after sporozoite
immunization
To determine whether antigen persists following irradiated
sporozoite immunization we transferred high numbers of CFSE
labeled TCR transgenic Thy1.1+ CD8+ T cells specific for the
CS protein of P. yoelii (hereafter referred to as ‘‘transgenic cells’’)
into mice that had been immunized 14 days previously with
irradiated P. yoelii sporozoites or naı¨ve control animals. We found
that transgenic cells in previously immunized mice, but not naı¨ve
controls, had some dilution of the CFSE label showing that some
of the cells had proliferated (Figure 1). T cell proliferation was not
seen among polyclonal T cells from WT Thy1.1+ mice
transferred to immune mice, indicating that proliferation was
antigen specific and not due to bystander activation (Figure 1).
Moreover, immunization with the related parasite P. berghei which
express a different CD8+ epitope not recognized by our
transgenic cells also failed to induce specific T cell proliferation
further excluding the possibility of bystander activation
(Figure S1A).
In the previous experiment, the proliferation of transgenic cells,
transferred weeks after initial immunization, suggested the
presence of persisting antigen. However, since T cell proliferation
was limited we initially hypothesized that the amount of antigen
that persists may be small and the phenomenon of marginal
significance. Alternatively, we reasoned that the transfer of high
numbers of transgenic cells might be inhibiting a more robust
proliferative response that might be seen with more physiological
numbers of cells [21]. Accordingly, we titrated different numbers
of labeled transgenic cells into previously immunized mice and
later isolated the transgenic cells from the spleen by magnetic bead
separation to determine the degree of proliferation in the antigen
specific cell population (Figure S2). Strikingly the extent of
transgenic cell proliferation substantially increased if fewer
precursor cells were used (Figure 2A): in mice that received
26106 cells only ,50% of the recovered cells had proliferated -
most of them fewer than 6 times; however, in mice that received
more physiological numbers of transgenic cells essentially all the
transgenic cells had divided and diluted out the CFSE label
completely. Similarly to earlier experiments, P. berghei immuniza-
tion did not induce transgenic cell proliferation even if low
numbers of cells were transferred (Figure S1B). In subsequent
experiments where we wished to analyze the differentiation of cells
primed by persisting antigen, a low number of cells (26103) was
transferred; where we were concerned with detecting only the
presence or absence of persisting antigen higher numbers of cells
were used (16104–26105) which removed the need for technically
challenging T cell purification.
Using this sensitive in-vivo assay to measure continued antigen
presentation, we were able to detect antigen in mice immunized
up to 60d previously (Figure 2B). Importantly, we also found
robust proliferation among transgenic cells transferred to mice that
had been immunized 2 weeks previously via the bites of infected
mosquitoes - the natural route - indicating that antigen persistence
Figure 1. Prolonged antigen presentation after sporozoite
immunization. 26106 Thy1.1+ CD8+ T cells from either TCR transgenic
or WT animals were transferred into groups of naı¨ve mice or mice
immunized 2 weeks previously with 56104 irradiated P. yoelii sporozo-
ites. 10 days after cell transfer the spleen cells from the recipient mice
were analyzed by FACs. Histograms show CFSE profiles of the Thy1.1+
CD8+ cell populations in each group. Values are the mean 6 SE of the
percentage of divided cells (n = 3, data from one of two similar
experiments shown).
doi:10.1371/journal.ppat.1000877.g001
Author Summary
Malaria causes the deaths of 0.5–2 million people each
year, mainly in Africa. A safe and effective vaccine is likely
needed for the control or eradication of this disease. It has
been shown that if people are bitten by malaria-infected
mosquitoes that have been irradiated they are protected
against fully infectious bites. Radiation makes the parasites
in the mosquito (called sporozoites) incapable of dividing;
however, the irradiated parasites are still capable of
stimulating the immune system to provide protection
against fully infectious parasites. Many trial vaccines are
based on trying to simulate the immune response induced
by irradiated sporozoites in a safe and cost-effective way.
We want to know how sporozoites are able to efficiently
induce immune responses. We found that sprozoite
molecules are retained by the immune system for months
after immunization. These molecules continue to stimulate
the cells of the immune system such that they divide more
and thus probably protect better. The ability of the
immune system to retain parasite material long after the
parasites themselves have disappeared is remarkable and
gives new insights into how effective immune responses
can be generated by vaccines.
Antigen Persistence after Malaria Immunization
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is a physiological phenomenon and not an artifact of needle
injection of sporozoites (Figure 2C).
Prolonged antigen presentation does not depend on the
presence of parasite remnants in the liver
It has been previously hypothesized that antigen persists in the
liver as exo-erythrocytic remnants following irradiated sporozoite
immunization [5]; in this study these remnants were not detected
after live sporozoite infection, or in mice that were immunized
with irradiated sporozoites and subsequently treated with
primaquine (PQ) [5]. To determine if such exo-erythrocytic
remnants could be the source of antigen that we detect, we
immunized mice with irradiated sporozoites and treated with PQ
7 days later. The dose, route and timing of PQ treatment were as
described in the original study [5]. Surprisingly, we found that PQ
treatment did not have an effect on the presence of antigen after
immunization (Figure 3). Moreover when we challenged with live
parasites followed by pyrimethamine treatment we also detected
persisting antigen (Figure 3). Nonetheless we determined that
metabolically active parasites (live or irradiated) are required for
the establishment of antigen persistence as antigen was not
detected after immunization with heat-killed sporozoites (Figure 3).
Together these data show that while metabolically active live or
attenuated parasites are required to establish antigen persistence,
this persistence does not require continued parasitic infection.
Antigen persists in the lymph node draining the site of
immunization, the spleen and the liver
Given that antigen does not appear to persist as exo-erythrocytic
forms in the liver, we hypothesized that it may be retained in
lymphoid organs, particularly those draining the site of immuni-
zation. To test this, mice were immunized i.v. or intra-dermally
(i.d.) in the right ear. Fourteen days later labeled transgenic cells
were transferred to the mice. When sporozoites were injected i.v.
significant numbers of dividing T cells were observed in the spleen
but not in the lymph nodes of mice (Figure 4A). In contrast,
following i.d. immunization, dividing cells were seen in the
draining auricular lymph nodes as well as the spleen. Significantly,
10-fold more dividing cells were seen in the draining right
auricular lymph nodes compared to the non-draining left auricular
lymph nodes (Figure 4A and B), indicating that antigen is retained
in the lymphoid tissues where sporozoite antigen is first trapped
and presented to naı¨ve cells. In addition we also saw cells dividing
in the spleen and liver, the divided cells found in these organs
Figure 2. Duration of antigen presentation, and antigen persistence after mosquito biting. A. Mice were immunized with 56104
irradiated sporozoites i.v. and 14 days later 26103–26106 CFSE labeled transgenic cells were transferred to the mice and to unimmunized controls.
Ten days later transgenic cells were enriched from the spleen and their CFSE profile determined by FACs. Representative plots from one of three mice
per group are shown. Values given are the total number of divided transgenic (CD8+ Thy1.1+ CFSElo) cells isolated from the spleen and in
parentheses the % of total recovered transgenic cells that have divided (data representative of numerous similar experiments). B. Mice were
immunized as in A. and 16104 transgenic cells were transferred to mice at different time points after immunization. Ten days after transfer the cells
were recovered and the number of divided transgenic cells recovered was determined (n = 3, mean 6 SE; data representative of two similar
experiments). C. Three mice were bitten by 8–10 infected P. yoelii infected mosquitoes. Fourteen days later 16104 transgenic cells were transferred to
the mice and 10 days later the number of divided transgenic cells was determined. Bars represent values for individual mice; data shown from two
independent experiments (i and ii).
doi:10.1371/journal.ppat.1000877.g002
Antigen Persistence after Malaria Immunization
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following i.d. immunization could have migrated from the ear
draining lymph node or they could have been primed in-situ. To
distinguish these possibilities another group of mice that received
parasites i.d. was given daily injections of 30 mg FTY720 after T
cell transfer to prevent the egress of activated T cells from the
lymph nodes in which they are primed [22]. In drug treated
animals we saw an increased accumulation of activated cells in the
draining lymph node, the spleen and the liver (Figure 4A and B)
suggesting that the spleen and liver might also be sites of antigen
retention. Previously we determined that lymphoid organs, chiefly
the skin-draining lymph nodes, but also the spleen, are the
principal sites of T cell priming [23] – here we show that antigen is
mainly retained in these sites. We also find some evidence of
antigen persistence in the liver, which cannot be excluded as a site
of T cell priming.
Professional APCs are required for prolonged antigen
presentation
Since antigen persists in both lymphoid and non-lymphoid
tissues we investigated the roles that professional APCs such as
myeloid DCs, macrophages or plasmacytoid DCs may play a role
maintaining and presenting antigen over the long term. Mice were
depleted of APC subsets at one of two time-points – either before
immunization on d0 or after immunization and prior to the
transfer of transgenic cells on d14 (ie. at the time we detect
persistent antigen presentation). To assess the role of DCs we used
mice which express the diphtheria toxin receptor under the control
of a CD11c promoter; DCs can be depleted in these animals with
low doses of diphtheria toxin (DT) [24]. Macrophages were
depleted from WT mice using clodronate liposomes (CL) [25]
while plasmacytoid DCs were depleted using the mAb 120G8
[26]. DT treatment of CD11c-DTR transgenic mice resulted in
,90% depletion of CD11c+ cells, while clodronate lipsome
depletion induced ,90% depletion of CD11bint F4/80-,
CD11bintF4/80+ and CD11bhiF4/80+ macrophage populations
(Figure S3). Interestingly we found that depletion of CD11c+ cells
in DTR mice and treatment with CL had similar effects. In both
cases, depletion at the time of immunization eliminated persisting
antigen (Figure 5A and B). It may be that DCs and macrophages
may be acting co-operatively to trap and retain antigen.
Alternatively since the treatments are not mutually exclusive
(Figure S3) a single cell type that is depleted by both treatments,
for example immature DCs, may be important for antigen
persistence.
Most strikingly, however, we found that neither depletion
protocol had any effect on prolonged antigen presentation if the
treatments were given after immunization (Figure 5 A and B). This
may indicate that antigen is transferred to another cell type
altogether for presentation. Transfer of antigen between APCs is
not unprecedented – herpes simplex virus antigen is trapped by
dermal DCs in the skin and transferred to lymph node DCs for
presentation [27]. Alternatively the antigen retaining macrophage
or DC may continue to present the antigen but become resistant to
depletion – a mature APC may become non-phagocytic or
downregulate CD11c.
In contrast to CL or DT treatment, administration of the
120G8 antibody had no effect on antigen persistence at any time-
point, likely ruling out a role for plasmacytoid DCs in the retention
or presentation of persisting antigen (Figure 5C), though the
efficacy of depletion was only around 70% (Figure S3). Finally we
excluded a role for B cells in antigen persistence since antigen
persisted in Jh mice which constitutively lack these cells (Figure 5D
[28]).
Prolonged antigen presentation maximizes the size of
the effector CD8+ T cell population and induces
proliferation of memory CD8+ T cells
Prolonged antigen presentation may contribute to the develop-
ment and maintenance of immune responses in a variety of ways.
Initially we asked how long cells had to be exposed to antigen in
order to maximize their expansion and development. To do this
we transferred 26103 transgenic cells to mice which were then
immunized with irradiated P. yoelii sporozoites. Four and seven
days after immunization, the primed effector cells were purified
and transferred either into mice that had been immunized on d0
with P. yoelii and thus continue to see the relevant antigen, or into
mice that had been immunized with P. berghei, where they are no
longer exposed to cognate antigen (Figure 6A; Figure S1).
Importantly, by four days after immunization essentially all the
Thy1.1 transgenic cells are effector cells that have been primed by
antigen and proliferated (Figure S4). A month after cell transfer we
measured the magnitude of the resulting memory cell populations
in the two groups of mice. When cells were transferred to P. yoelii
immunized mice at day 4 they formed a memory population that
was ,13 times larger than that formed by cells transferred to
P.berghei immunized mice (Figure 6B). However, after day 7 the
magnitude of the response did not depend on the presence of
antigen. The requirement for antigen exposure for 4–7 days was
striking as previously it has been reported that T cells require only
a brief (,24 hour) exposure for their development [6,7]. Finally
we found that cells that were only exposed to antigen for 4 days
had similar cytokine profiles upon re-stimulation to cells
continuously exposed to antigen (Figure S5), suggesting that
longer antigen presentation is not required for the differentiation
of cells but to maximize their expansion.
To determine the effect that long term antigen presentation has
on fully differentiated memory cells we transferred d60 memory
cells to mice that had received antigen 0–42 days previously
(Figure 6C). Differently to effector cells, we found that antigen
could induce the proliferation and expansion of d60 memory cells
Figure 3. Prolonged antigen presentation does not depend on
the presence of parasite. Mice were immunized i.v. with 56104 of
each of irradiated sporozoites, irradiated sporozoites followed by 2
doses of PQ treatment 10 hours apart 7 days after immunization, live
sporozoites (with pyrimethamine treatment to remove blood stage
parasites) and heat killed sporozoites,. Fourteen days later 26105
transgenic cells were transferred to the immunized and naı¨ve mice, 10
days after transfer the number of transgenic cells/ spleen was
determined for each group of mice (n = 3, mean 6 SE; data from one
of three experiments).
doi:10.1371/journal.ppat.1000877.g003
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up to 28 days after immunization (Figure 6D). Similar results were
obtained with d200 memory cells. In contrast memory cells
transferred to naı¨ve mice did not undergo significant proliferation.
Thus it appears that the responsiveness of cells to persisting
antigen correlates with their activation status – naı¨ve cells are
exquisitely sensitive to antigen (Figure 2), while resting memory
cells can also turn over in response to antigen. On the other hand
beyond 4–7 days of activation effector cells appear to be
independent of antigen.
Priming of thymic emigrants by persisting antigen
The previous experiments demonstrate that a prolonged period
of antigen presentation throughout the expansion phase of the
CD8+ T cell response is required to maximize the CD8+ T cell
response. However antigen continues to be presented for weeks
after this. In addition to showing that this late antigen presentation
could stimulate the proliferation of memory cells we also
hypothesized that prolonged antigen presentation may continue
to recruit naı¨ve cells, such as naı¨ve thymic emigrants to the
immune response. To test this we immunized mice with
sporozoites and 3 days later depleted CD8+ T cells by antibody
treatment. Preliminary experiments showed that this treatment has
no effect on the presence of persisting antigen (data not shown).
Around 10 days after depletion, CD8+ T cells begin to reappear,
these repopulating cells are, in all likeliness, mostly thymic
emigrants (Figure 7A). Thirty-five days after immunization we
isolated the endogenous tetramer+ cells by magnetic bead
selection and stained for the surface markers CD44 and CD62L.
We found antigen specific thymic emigrants from immune mice
expanded ,2.5-fold compared to cells in naı¨ve mice - a difference
that was significant (Figure 7B; P = 0.027 by two-tailed T test;
t = 2.58; df = 10). More importantly, thymic emigrants had up-
regulated CD44 and down-regulated CD62L, a phenotype similar
to that seen in immunized mice which had received control IgG
instead of anti-CD8 (Figure 7C and 7D) suggesting that thymic
emigrants are indeed primed by persisting antigen.
It is possible that some of the tetramer+ activated cells we see
after depletion are not thymic emigrants but cells that survived
anti-CD8 depletion and subsequently expanded by homeostatic
proliferation. To estimate the likely percentage of such cells we
transferred 26103 transgenic Thy1.1+ cells to two further groups
of Thy1.2+ mice that were immunized with sporozoites. We then
compared the ratio of Thy1.1+ transgenic and Thy1.2+
endogenous tetramer+ cells in CD8+ depleted and non-depleted
animals. If the activated cells we see after depletion are survivors of
this depletion we would not expect this ratio to change, on the
Figure 4. Antigen persists in the draining lymph nodes. A. Mice were immunized i.v. or i.d. with 56104 irradiated sporozoites. Fourteen days
later 16104 CFSE labeled transgenic cells were transferred to the mice, some of the mice that had been immunized i.d. received daily doses of 30 mg
FTY720 after cell transfer to prevent egress of primed T cells. Eight days after cell transfer transgenic cells were enriched from various tissues by
positive selection. Flow cytometry plots show representative data from each group. Values are the mean 6 standard deviation of the number of
divided transgenic cells recovered per tissue of three mice per group. B. Histograms of the data presented in A. (n = 3, mean6 SE, P.0.05, * = P,0.05,
*** = P,0.001). Data in A and B are representative of four similar experiments.
doi:10.1371/journal.ppat.1000877.g004
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other hand if few cells survive the depletion then a smaller
proportion of the cells will be Thy1.1+ as these cells can not be
replaced by thymic emigrants. The ratio of transgenic cells:endo-
genous cells was 1.2:1 in depleted mice but 6.9:1 in undepleted
animals (Figure S6), a significant difference from what would be
expected if the tetramer+ cells in CD8+ treated animals were only
depletion survivors (P,0.0001 by Fisher’s exact test). By
comparing these ratios (1.2/6.9) we estimate that ,17% (95%
CI: 12–27%) are likely to be depletion survivors whereas .80% of
the response can likely be attributed to thymic emigrants.
Persisting antigen can induce naı¨ve T cells to
differentiate into functional effector and memory T cells
We further wished to determine whether primed thymic
emigrants could become functional effector and memory cells.
However we were limited by the small number of cells in the
endogenous response. To mimic the response of thymic emigrants
we transferred 26103 naı¨ve transgenic cells to mice that were
immunized 14–60 days previously and compared the phenotypes
of these cells (persistent antigen primed cells) to those primed by
immunization on the same day as cell transfer (early antigen
primed cells). Seven days after cell transfer we measured the
surface phenotypes of transgenic cells. T cell populations primed at
all time points had significantly upregulated CD44 and downreg-
ulated CD62L suggesting that persisting antigen can drive the cells
to form an effector population (Figure 8A i and ii), however some
cells primed at day 42 and 60 had not down regulated CD62L as
much as cells primed at earlier time points (Figure 8A ii). These
cells may be less differentiated than cells primed earlier in the
response as indicated by the fact that fewer cells had undergone 6
or more divisions (Figure 8A iii). Crucially, however, when we
compared the polyfunctional cytokine profile 35 days after cell
transfer we found no significant differences in the functionality of
the cells: production of IFN-c, TNF-a or IL-2 was similar
regardless of whether those cells had been primed early in the
response or by persisting antigen on d14 or d28 (Figure 8B). To
verify that the cells primed by persisting antigen could be bona-
fide memory cells we tested their ability to mount recall responses.
When 26103 persistent antigen primed cells were transferred to
naı¨ve mice and boosted with a vaccinia virus expressing the
SYVPSAEQI epitope they expanded better than memory cells
primed by early antigen (Figure 8C).
Cells primed weeks after immunization can inhibit
parasite development
To determine if persistent antigen primed cells could develop
anti-parasite acitivity we transferred transgenic cells to mice that
had been immunized 14 days previously. Mice that received
transgenic cells had been depleted of CD8+ cells on days 3 and 4
after immunization, to ensure that the only sporozoite specific
effector CD8+ cells present in these mice would have been primed
by persisting antigen. Seven days after cell transfer the mice were
challenged with live P. yoelii sporozoites and the parasite load
measured in the liver. Compared to naı¨ve control mice - which
Figure 5. CD11c+ and phagocytic cells are required for continued antigen presentation. A. CD11c-DTR and WT mice were immunized i.v.
with 56104 irradiated sporozoites at day 0. Groups of CD11c-DTR and wild-type mice were treated with 100ng of DT on the indicated days. On day
14, 26105 CFSE labeled transgenic cells were transferred to the mice. Ten days later, the number of divided transgenic cells was determined by FACs
(n = 3, mean 6 SE, * = P,0.05, ** = P,0.01, data representative of four experiments). B. Groups of mice were immunized on day 0 as in A and treated
with clodronate liposomes (200 ml i.v./mouse) at the indicated days to deplete splenic macrophage populations. On day 14, 26105 CFSE labeled
transgenic cells were transferred to the mice. Ten days later, the number of divided transgenic cells was determined by FACs (n = 3, mean 6 SE,
* = P,0.05 data representative of two experiments). C. Groups of mice were immunized on day 0 with irradiated sporozoites and treated with 200 mg
of the anti-plasmacytoid DC mAb 120G8 or control IgG at the indicated days. On day 14, 26105 transgenic cells were transferred to the mice. Ten
days later the number of divided transgenic cells was determined by FACs. (n = 3, mean 6 SE, data representative of two experiments). D. Jh (B cell
deficient) and WT mice were immunized with irradiated sporozoites. 14 days later 26105 transgenic cells were transferred to the mice. Ten days after
cell transfer the number of divided transgenic cells in immune mice was determined by FACs and compared to background proliferation of cells
transferred to naı¨ve mice (n = 3, mean 6 SE, ** = P,0.01, data representative of two experiments).
doi:10.1371/journal.ppat.1000877.g005
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had also been depleted of CD8+ T cells and received transgenic
cells – parasite development in immunized mice was inhibited by
approximately 50%. This level of anti-parasite activity was
significant (P = 0.0016 by two-tailed T test; t = 4.96; df = 7),
demonstrating that CD8+ cells primed by persisting antigen can
develop anti-parasite effector mechanisms and are likely to
contribute to protective immunity (Figure 9). Importantly, parasite
killing could not be attributed to antibodies, CD4+ T cells or
CD8+ T cells that survived depletion, since immunized mice that
were treated with anti-CD8 but did not receive transgenic
cells were infected just as readily as naı¨ve control animals
(Figure 9).
Discussion
In this study we show that CS antigen continues to be presented
for nearly 2 months following irradiated sporozoite immunization
– a striking result given that irradiated sporozoites are incapable of
replication and only transform abortively into early liver stages
[29,30]. Sporozoite antigen presented weeks after immunization
could prime naı¨ve T cells to acquire effector functions and become
capable of eliminating liver stage parasites. Importantly, curtailing
antigen presentation by transferring specific effector T cells to
mice without persisting antigen profoundly reduced the size of the
resulting memory cell pool.
The presence of persisting antigen following sporozoite
immunization has been proposed previously based on the
continuing presence of parasite remnants in the liver [5] though
the actual presence of antigen was not proven. In showing that
antigen specific cells proliferate in immunized but not control
mice, and that this effect cannot be attributed to inflammation, we
demonstrate for the first time that antigen does indeed persist after
sporozoite immunization. The use of a functional assay to detect
antigen is not only more definitive than detection by immunohis-
tochemistry, but probably also more sensitive as T cells can
proliferate in response to a single peptide-MHC Class I complex
[31]. Given our findings that (i) antigen persists in lymphoid tissue,
(ii) DCs and/or macrophages are required to establish antigen
persistence and (iii) antigen persistence does not appear to be
dependent upon the continuing presence of parasite forms in the
liver it is probable that the antigen persistence we observe is a
distinct phenomenon from that previously described. Indeed in
our system antigen may be persisting, not as parasite forms but as
protein or even MHC Class I complexes.
Because we describe a distinct aspect of sporozoite biology our
work does not directly address the controversial issue of whether
long-lived parasite forms in the liver are required to maintain
protection. In many studies PQ treatment to remove such exo-
erythrocytic remnants has been used to ablate protective immunity
after sporozoite immunization, [5,32,33,34]. However, other
investigators, including ourselves, have been unable to see an
effect of PQ on CD8+ T cell responses and immunity [35,36,37]
(Figure S7). Moreover, our data do not support the notion that PQ
treatment removes persistent antigen and thus abrogates immune
responses. In at least some experiments PQ was administered
hours after immunization with parasites [32,34] and its effect may
be due to the inhibition of responses to later liver stages or blood
stages rather than any effect on remnant parasite forms in the
Figure 6. Prolonged antigen presentation is required for optimal CD8+ memory formation. A and B. Naı¨ve mice received 26103
transgenic cells and were immunized on d0 with 56104 irradiated P. yoelii sporozoites. On either d4 or d7 CD8+ T cells were purified from these mice
and the equivalent of 56104 transgenic cells were transferred to recipients that had received 56104 irradiated P. yoelii sporozoites or 56104 irradiated
P. berghei sporozoites on d0. On d35 the size of the transgenic memory population was measured by FACs. A. Outline of the experiment. B. Size of the
resulting memory populations after cells transfer on (i) d4, (ii) d7 (n = 5, mean 6 SE, ** = P,0.01). C and D. BALB/c mice were immunized with 56104
irradiated sporozoites and 26103 d60 memory transgenic cells were transferred to mice at different time points after immunization. Ten days after
transfer the transgenic cells were recovered and the number of divided cells was determined C. Outline of the experiment. D Number of divided cells
recovered (n = 3, mean6 SE; a positive response is considered. upper 95% confidence interval of the response seen in naı¨ve mice, data from one of
two similar experiments).
doi:10.1371/journal.ppat.1000877.g006
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liver. Alternatively since PQ is a rather toxic drug [38] it may be
acting ectopically to inhibit immune responses.
These findings have profound implications for our understand-
ing of immunity after vaccination with irradiated sporozoites. The
irradiated sporozoite model of immunization against malaria is
one of the few vaccine models where CD8+ T cells play a major
protective role as T cells specific for a single epitope can
completely eliminate parasite infection in the liver [39]. Antigen
persistence probably plays a significant role in the development of
these protective CD8+ T cells. We found that after immunization
with heat killed, irradiated or live sporozoites antigen persistence
correlates with the ability to induce protective immune responses:
heat killed sporozoites induce very poor CD8+ T cell responses
[40], while both irradiated sporozoites and live sporozoites induce
robust protective CD8+ T cell responses [2,34]. While live or
attenuated sporozoites may potentiate immunity in a variety of
ways, for example by generating more antigen or eliciting danger
signals, our findings that prolonged antigen presentation recruits
cells to immune response and increases the number of memory
cells show that the ability to induce prolonged antigen presentation
may be a requirement for effective vaccination.
Our finding that prolonged antigen presentation is required for
maximal CD8+ T cell expansion and memory formation
apparently contrasts with experiments using different systems,
which suggest that only a short burst of antigen presentation is
required for full differentiation of CD8+ T cells [6,7,8]. How can
these differing results be reconciled? One explanation for
differences between studies is that powerful replicating immuno-
gens such as Listeria expressing ample danger signals such as TLR
ligands may be capable of efficiently priming T cells in a short
period of time. In contrast, Plasmodium sporozoites, a non-dividing
immunogen, may have more stringent requirements for T cell
priming, including a need for prolonged antigen presentation.
Alternatively, we might propose that antigen dose and time of
exposure are important for the magnitude of the immune
response, but, above a minimal threshold, may not be critical
for the quality of T cell activation. The uncoupling of T cell
differentiation from T cell expansion would also explain why T
cells primed by small amounts of persisting antigen can
differentiate similarly to T cells primed by larger amounts of early
antigen without the same degree of T cell expansion.
In addition to being important for the maximal proliferation of
effector cells, persisting antigen can recruit naı¨ve cells to the
immune response for at least 60 days after immunization and
induce proliferation of established memory cells. It has been
previously shown that thymic emigrants contribute significantly to
the immune response to chronic viral infections [14,15] – here we
show this process may also be important in the absence of ongoing
infection. Further work will be required to determine the relative
significance of the cells primed late compared to those primed
soon after immunization. It may be that the T cells primed in the
initial 4–7 days of antigen exposure are sufficient to establish
immunity. Alternatively cells primed late in the immune response
may have a role in the development of memory populations –
particularly, perhaps, central memory populations since in our
experiments late primed cells were more likely to be CD62Lhi and
expanded more readily upon boosting than early primed cells.
In addition to the roles prolonged antigen presentation plays in
maximizing the T cell response to immunization, our data show
that antigen persists following infection with live parasites. This
may have important implications for immune responses in
endemic areas where people are exposed to sporozoites on a daily
to monthly basis; if antigen is retained similarly in humans it would
mean many people would be permanently exposed to sporozoite
antigen [41]. There is some evidence that antigen persistence has a
positive role in these circumstances – T cell responses to P. vivax
which forms long lived hypnozoite stages in the liver are generally
more robust and long lived than responses to P. falciparum, at least
among travelers and individuals in areas of low transmission
[42,43]. However, paradoxically, given our results showing that
antigen persistence has a positive role in the development of
immune responses, T cell responses to sporozoite antigens are
generally considered rather poor in individuals in endemic areas
[44]. A variety of reasons have been given for limited responses in
endemic areas: we have shown that once established CD8+ T cells
have powerful feedback regulatory mechanisms that limit T cell
Figure 7. Persisting antigen primes naı¨ve thymic emigrants. A.
Outline of the experiment: mice were immunized with 56104 irradiated
sporozoites i.v. On days 3 and 4 after immunization some of the mice
were depleted of CD8+ cells such that the observed response consists
largely of later thymic emigrants (gray bars). Control mice were treated
with control IgG1 leaving the pre-existing response in tact (total
response – black bars), while other mice were left un-immunized but
treated with anti-CD8 (naı¨ve – white bars). B. Histograms of the number
of tetramer+ cells recovered in each group, bar charts show means6 SE
(n = 6, * = P,0.05, data pooled from two similar experiments). C.
Histograms of the percentage of activated cells (CD62Llo, CD44hi)
among the tetramer+ population recovered in each experiment (n = 3,
* = P,0.05, data from one of two similar experiments). D. Dot plots of
the CD62L and CD44 expression of tetramer+ cells in each group, data
show concatenated data from 3 animals per group and are from one of
two similar experiments.
doi:10.1371/journal.ppat.1000877.g007
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expansion. Under these conditions the magnitude of a T cell
response may be set by initial antigen exposure, which in the case
of mosquito bites will be small [35,45]. Thus while continued
antigen presentation may recruit cells to the sporozoite specific
immune response, the expansion of these cells may be continually
regulated by established effector and memory cells which compete
with naı¨ve cells for antigen. Since initial exposure is the most
important determinant of the threshold at which specific CD8+ T
cell responses are set, it is not surprising that a single immunization
with a very high number of irradiated sporozoites would give a
stronger response than natural exposure.
Using similar experimental approaches to those described here
antigen persistence has been studied following acute influenza and
vesicular stomatitis virus infections [16,17,18,19]. The process of
antigen retention is probably analogous between these systems and
ours: in all cases antigen is retained in lymphoid tissue in the
absence of detectable infection for a period of 1–2 months.
Nonetheless our results showing efficient formation of T cell
memory among cells primed by persisting antigen contrast with
some findings in other systems. Some studies using influenza virus
infection have suggested that persistent antigen presentation may
result in sub-optimal priming of naı¨ve T cells [19,46]. Such defects
might be explained by differences in the processing of sporozoite
and viral antigen. However it is also notable that all other studies
detecting persisting antigen using transgenic T cells have
employed the transfer of high (26105–16106) numbers of naı¨ve
transgenic cells. In preliminary experiments we also used un-
physiological numbers of transgenic cells and found evidence of
defective T cell priming, including the fact that ,15% of divided
cells produced any effector cytokine (Figure S8). If the differences
between our findings and those of other authors are based on
experimental rather than biological differences it maybe that
antigen retention is a common feature of the immune response to
many live pathogens.
Figure 8. Antigen presentation weeks after immunization can prime T cells to become functional effector cells. A. 26103 CFSE labeled
transgenic cells were transferred to mice that had been immunized 14, 28, 42 and 60d previously with 56104 irradiated sporozoites i.v. (persistent-
antigen activated cells – gray bars). Phenotypes of persistent antigen activated cells were compared to the phenotypes of early antigen activated
cells, in which 26103 transgenic cells were transferred to naı¨ve mice and immunized the same day with 56104 irradiated sporozoites (black bars).
Naı¨ve control mice received 26106 CFSE labeled transgenic cells. 7 days after cell transfer transgenic cells were isolated and analyzed for (i) CD44
expression, (ii) CD62L expression, and (iii) CFSE dilution (n = 3, means 6 SE, ns = not significant, * = P,0.05, ** P,0.01, data from four similar
experiments). B. Polyfunctional analysis comparing the cytokine expression of cells stimulated by early (d0) or persisting antigen (d14 or d28) 35 days
after cell transfer. i. histogram shows the % of transgenic cells producing each possible combination of cytokines in response to early antigen
presentation (black bars), d14 antigen presentation (gray bars) or d28 antigen presentation (white bars) ii. pie charts representing the number of cells
producing 3 (red), 2 (blue), 1 (yellow) or 0 (gray) cytokines (data from three similar experiments). C. 26103 naı¨ve transgenic cells (white bar), 26103
d35 memory transgenic cells primed by early antigen (black bar) and 26103 d35 memory transgenic cells primed by persisting antigen (gray bar)
were transferred to naı¨ve BALB/C mice which were immunized with 26106 VV-SYV i.v., 14 days later the number of Thy1.1+ transgenic cells was
measured by FACs (n = 3, mean 6 SE, data from two similar experiments).
doi:10.1371/journal.ppat.1000877.g008
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Determining the cells involved in retaining and presenting
persisting antigen is an area for further investigation. Professional
antigen presenting cells clearly play a role in prolonged antigen
presentation. Both CD11c+ cell depletion in DTR transgenic mice
and CL treatment in WT mice at the time of immunization almost
completely abrogated antigen persistence. These data strongly
suggest a role for CD11c+ DCs and macrophages in antigen
persistence. However since DT treatment also removes some
macrophages and clodronate liposomes can deplete some DCs
(Figure S3; [47]) it is possible that only a single cell type that is
depleted by both treatments is important for prolonged antigen
presentation. Strikingly, we were unable to deplete the cells that
actually present antigen weeks after immunization. The simplest
explanation for these data would be that CD11c+ cells acquire
antigen and transfer it to another depletion resistant cell for
continued presentation. Transfer of antigen between cell popula-
tions has been described previously in a variety of systems so this is
not implausible [27,48,49]. Lymphoid stromal cells which have
been shown to be capable of presenting self antigens could be one
candidate recipient cell population [50]. Some studies suggest that
stromal cells can acquire antigen from B cells and develop into
follicular dendritic cells (FDCs) [51], an analogous process could
be occurring for T cell antigen. In our system, mature FDCs
themselves are unlikely to be the presenting cell type as these cells
are not apparently found in the absence of B cells [52], while we
detect antigen persistence in B cell deficient animals. Alternatively
rather than transferring antigen to another cell type, DCs or
macrophages might retain antigen themselves but become
refractory to depletion, this may happen if an antigen retaining
cells down-regulate expression of CD11c or phagocytic processes.
Nonetheless, the idea of long-lived antigen presenting DCs
contradicts the prevailing view that DCs generally undergo rapid
turnover [53]. Given that cells retaining antigen are rare and hard
to isolate, identifying the relevant cell type is difficult using existing
techniques and assays.
Together these data show that antigen may persist following
immunization with a non-replicating immunogen. This antigen
persistence appears able to enhance the immune response to
pathogens by continually recruiting naı¨ve cells into the protective
immune response and maximizing the expansion of pathogen
specific effectors. These observations clearly have important
implications for the design of vaccines particularly those based
on attenuated or non-replicating pathogens.
Materials and Methods
Ethics statement
All animal procedures were approved by the Institutional
Animal Care and Use Committee of the Johns Hopkins University
(Protocol Number MO09H41) following the National Institutes of
Health guidelines for animal housing and care.
Mice
5–8 week old female BALB/C were purchased from Taconic
(Hudson, NY). Transgenic mice expressing a TCR specific for the
P. yoelii epitope were derived as previously described [54]. Mice
from our colony that have previously been backcrossed to the
Thy1.1+ BALB/C background for .20 generations were used.
CD11c-DTR mice on a BALB/C background were derived as
described and are maintained in our colony as heterozygotes [24].
Jh mice deficient in have been described previously [28] and were
purchased from Taconic. Experiments involving mice were
approved by the institutional animal care and use committee of
the Johns Hopkins University.
Immunizations and drug treatment
P. yoelii 17X NL and P. berghei ANKA sporozoites were obtained
and irradiated as previously described [54]. The dose of radiation
required to fully attenuate sporozoites was 40kRad for P. yoelii and
20kRad for P. berghei. Immunizations (56104 sporozoites unless
otherwise stated) were given i.d. in the right ear where possible
[23]. In some experiments it was necessary to use i.v.
immunization to obtain enough material from the spleen for
phenotypic analysis; i.v. immunization was also necessary in
depletion experiments as treatments such as clodronate liposomes
do not deplete efficiently in peripheral tissues when given
systemically [25]. Sporozoites were heat killed by incubation at
65uC for 15 minutes. To prevent blood stage infections following
live sporozoite infection mice were treated from 40 hours to 7 days
after immunization with pyrimethamine at 70 mg/ml in the
drinking water. In some experiments PQ was administered in 2
doses of 60mg/kg s.c., 10 hours apart 7 days after sporozoite
immunization; this treatment is effective but highly toxic, of 10
control mice infected with 56103 P. yoelii sporozoites and treated
with 60mg/kg PQ 10 and 20 hours after challenge, 4 died of drug
treatment though the remaining 6 did not develop parasitemia.
Quantification of parasite RNA
Quantification of liver stage parasites was as previously
described [55]. Briefly, 40–42 hours after challenge, livers were
excised and parasite load was determined by quantitative PCR for
P. yoelii 18S rRNA using SYBR Green (Applied Biosystems).
Cell depletion
DCs were depleted from CD11c-DTR transgenic mice by 2 i.p.
injections of 100ng DT 3 days apart. This resulted in
approximately 90% depletion of DCs for around 120 hrs.
BALB/C mice are able to accept this dose without weight loss
or the mortality seen in C57/B6 mice [56]. CD8+ cells were
depleted by 2 i.p. injections on consecutive days with 200 mg anti-
CD8 (clone 2.43). Clodronate liposomes were prepared and used
as described [25], clodronate was a gift of Roche Diagnostics
GmbH, Mannheim, Germany. To deplete plasmacytoid DCs
Figure 9. Cells primed weeks after immunization can inhibit
parasite development. Two groups of mice were immunized with
36104 irradiated sporozoites i.d. in the right ear on d0 and depleted of
the endogenous CD8+ T cell response on days 3 and 4. Some of these
mice received 26103 transgenic cells on d14 (white bar) while others
did not receive cells (gray bar). Naı¨ve control mice were similarly
depleted of CD8+ T cells on days 3 and 4 and received transgenic cells
(black bar). All mice were then challenged on d21 and euthanized 40
hours later. Parasite burdens in the liver were measured by RT-PCR
(mean 6 SE, * = P,0.05, ** = P,0.01, data from one of two experiments
shown).
doi:10.1371/journal.ppat.1000877.g009
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mice were treated on consecutive days with 100 mg of the rat mAb
120G8 as described previously [26].
Cell isolation and preparation of samples for flow
cytometry
Single cell suspensions of lymphocytes were obtained by
grinding spleen cells or lymph node cells between the ground
ends of two microscope slides and filtering twice through 100 mm
nylon mesh. Liver lymphocytes were isolated from perfused livers
by grinding, filtration through a 70 mm mesh and separation over
a 35% percoll gradient as described [57]. Where necessary,
untouched purified populations of CD8+ T cells were obtained
using the mouse CD8+ T cell isolation kit according to the
manufacturers instructions (Miltenyi Biotech, Auburn, CA). Rare
antigen specific cell populations were enriched as previously
described [58,59,60]. Briefly cells were incubated with anti-
Thy1.1-PE (if transgenic cells were being enriched) or Tetramer-
PE (if the endogenous population was being examined). The cells
were then positively selected by magnetic bead separation using
anti-PE microbeads and LS columns (Miltenyi Biotech). To
identify the antigen specific cells of interest the cells were co-
stained with CD8, while irrelevant cells were excluded by staining
with a dump gate pool of CD11b, CD4 and B220. To analyze the
expression of T cell activation markers cells were also stained
simultaneously with anti-CD44, CD27 and CD62L and analyzed
on a LSR-II flow cytometer (BD Biosciences).
Polyfunctional cytokine assay
For analysis of T cell functionality based on cytokine
production, cells were incubated with peptide-coated target
cells in the presence of protein transport inhibitors and then
stained for intracellular cytokines. Briefly, A20 target cells were
pulsed with SYVPSAEQI peptide (2 mg/mL) and control A20
cells were incubated without peptide. Peptide-coated or control
target cells (66105 per well) were added to a 96-well V-bottom
plate with 26106 effector cells. To measure cytokine produc-
tion, cells were incubated with brefeldin A (GolgiPlug, BD
Biosciences) to block protein transport. Cells were stimulated for
5 hours at 37uC and then washed twice in cold media and then
surface stained with anti-CD8 (clone 53–6.7) and anti-Thy-1.1
or dump gate antibodies as required. Cells were then
permeabilized and fixed using a Cytofix/Cytoperm kit (BD
Biosciences) according to the manufacturer’s instructions and
stained for intracellular cytokines using anti-IFN-c (clone
XMG1.2), anti-TNF-a (clone MP6-XT22), or anti-IL-2 (clone
JES6-5H4, all from eBiosciences) at pre-determined concentra-
tions. Cells were then washed and analyzed on a LSR II flow
cytometer (BD Bioscience).
Data analysis
Statistical analysis was performed using Prism 4 software
(GraphPad Software), unless otherwise stated, means were
compared by two-tailed Student’s t tests. Analysis of all FACS
data was performed using FlowJo software (TreeStar). Seven color
samples were compensated using matrices generated with the
single color controls and FlowJo software. For analysis of
polyfunctionality, single gates were drawn for IFN-c+, TNF-a+,
and IL-2+ cells among CD8+Thy-1.1+ lymphocytes (gates were
set using control non-stimulated transgenic cells). Boolean
combination gates were then created to generate the 8 possible
functional groups from the 3 individual functions. Data was
exported to PESTLE and SPICE (both kindly provided by Mario
Roederer) for analysis.
Supporting Information
Figure S1 Proliferation of transgenic cells is not due to an
ongoing inflammatory response. A. 2 6 106 Thy1.1+ CD8+ T
cells from TCR transgenic were transferred into mice immunized
2 weeks previously with either 5 6 104 irradiated P. yoelii
sporozoites or 5 6 104 irradiated P. berghei sporozoites. 10 days
after cell transfer the spleen cells from the recipient mice were
analyzed by FACs. Histograms show representative CFSE profiles
of the Thy1.1+ CD8+ cell populations in each group. (n = 3, data
from one of two similar experiments shown). B. As in A except
only 26 103 transgenic cells were transferred.
Found at: doi:10.1371/journal.ppat.1000877.s001 (2.25 MB TIF)
Figure S2 Identification of rare transgenic cell populations. 26
103 CFSE labeled transgenic cells were transferred to mice that
had been immunized 14 days previously with 56 104 irradiated
sporozoites. 10 days later the mice were sacrificed and the spleens
taken. The cells were stained with anti-Thy1.1 PE and then
incubated with anti PE-microbeads (Milteyi Biotech) before
positive selection using an LS column. Cells were then counter
stained with anti CD11b, anti-CD4 and anti-B220 (all conjugated
to PE-Cy7) and anti-CD8 APC and analyzed by FACs. Rare
transgenic cells could then be identified using the gating protocol
shown and the extent of proliferation determined from CFSE
dilution.
Found at: doi:10.1371/journal.ppat.1000877.s002 (1.71 MB TIF)
Figure S3 Depletion of dendritic cell and macrophage subsets.
A. CD11c-DTR mice were treated with 100ng DT or PBS as a
control. One day later the efficacy of depletion was assessed by
FACs. Plots show (i) % of cells CD11c+ DTR-GFP+ (gated on
CD3- granulocytes) and (ii) partial depletion of macrophage
subsets in DT treated animals, (gated on CD11c- CD3-
granulocytes). B. BALB/C mice were treated once with 200ml
clodronate liposomes, 8 days later the depletion of macrophage
subsets was assessed by FACs. Plots show (i) the depletion of
CD11b+ and F4/80+ subsets (gated CD11c- CD3- granulocytes)
and (ii) partial depletion of CD11c+ cells (gated on CD3-
granulocytes). C. BALB/C mice were treated on consecutive days
with 200mg120G8 or Rat IgG. One day later the efficacy of
depletion of CD11c+ B220+ plasmacytoid DCs was assessed by
FACs (plots gated on CD11c+ granulocytes).
Found at: doi:10.1371/journal.ppat.1000877.s003 (5.74 MB TIF)
Figure S4 Proliferation of cells four days after immunization. 2
6 103 CFSE labeled Thy1.1 transgenic cells were transferred to
mice which were immunized with 5 6 104 P. yoelii irradiated
sporozoites. Four days later the Thy1.1+ cells were enriched as
described and the proliferation of T cells was assessed by CFSE
dilution and compared to naı¨ve controls (representative data from
one of three mice per group shown).
Found at: doi:10.1371/journal.ppat.1000877.s004 (1.09 MB
TIF)
Figure S5 Polyfunctional profiles of cells transferred to P. yoelii
and P. berghei immunized mice. Polyfunctional analysis of
transgenic T cells in Figure 6Bi: Naı¨ve mice received 2 6 103
transgenic cells and were immunized on d0 with 5 6 104
irradiated P. yoelii sporozoites. On either d4 CD8+ T cells were
purified from these mice and 5 6 104 transgenic cells were
transferred to recipients that had received 5 6 104 irradiated P.
yoelii sporozoites or 56104 irradiated P. berghei sporozoites on d0.
On d35 polyfunctional analysis was performed on transgenic T
cells recovered from these mice. A. Histograms showing the
polyfunctional profile of transgenic cells that had been transferred
to P. berghei immunized (black bars) and P. yoelii immunized mice
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(white bars) 4 days after priming (n = 3, mean 6 SE). B. Pie charts
showing the number of transgenic cells producing 3, (red), 2 (blue),
1 (yellow) or 0 (gray) cytokines.
Found at: doi:10.1371/journal.ppat.1000877.s005 (3.03 MB TIF)
Figure S6 Activated cells seen after CD8+ T cell depletion likely
represent recent thymic emigrants. Mice received 2 6 104
Thy1.1+ transgenic cells prior to immunization with 5 6 104
irradiated sporozoites. On days 3 and 4 after immunization the
mice were treated with either anti-CD8+ mAbs or rat IgG1 as a
control. 35 days after immunization the magnitude of the tetramer
+ve response was determined and the proportion of Thy1.1+ cells
was determined in both groups. Data show the mean 6 SE of the
number of tetramer +ve cells per group based on 3 mice per
group; this experiment was performed concurrently with that
shown in Figure 7.
Found at: doi:10.1371/journal.ppat.1000877.s006 (2.35 MB TIF)
Figure S7 Primaquine treatment does not affect parasite killing
in sporozoite immunized mice. Mice were immunized i.v. with 56
104 irradiated sporozoites (gray bars) and challenged 37 days later
with 5 6 103 live sporozoites with or without primaquine
treatment (as in A) on day 7. 40 hours after challenge parasite
load was measured in the liver by RT-PCR and compared to
naı¨ve controls (black bars; n = 3, mean 6 SE).
Found at: doi:10.1371/journal.ppat.1000877.s007 (1.20 MB TIF)
Figure S8 Transgenic cells do not acquire full effector function
in response to persisting antigen when high numbers of precursors
are used. 26 106 CFSE labeled transgenic cells were transferred
to mice that had been immunized 2 weeks previously with 56104
irradiated sporozoites or to naı¨ve mice which were immunized the
same day as transfer. 10 days later the spleens were taken, re-
stimulated with peptide and polyfunctional analysis performed. A.
The percent of CFSElo cells producing each effector cytokine
(representative data of one of three mice per group, gated on
Thy1.1+ CD8+ T cells). B. i histograms showing the polyfunc-
tional profile of transgenic cells that had encountered early (black
bars) and persistent (gray bars) antigen presentation (n = 3, mean
6 SE) and ii pie charts showing the number of CFSElo transgenic
cells producing 3, (red), 2 (blue), 1 (yellow) or 0 (gray) cytokines.
Representative data from two similar experiments shown.
Found at: doi:10.1371/journal.ppat.1000877.s008 (5.44 MB TIF)
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